Caplin Point Laboratories Ltd (BOM:524742)
₹ 1380.4 -18.05 (-1.29%) Market Cap: 104.83 Bil Enterprise Value: 96.49 Bil PE Ratio: 22.99 PB Ratio: 4.53 GF Score: 98/100

Q1 2021 Caplin Point Laboratories Ltd Earnings Call Transcript

Aug 11, 2020 / 10:30AM GMT
Release Date Price: ₹536.15 (-6.02%)
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY '21 Earnings Conference Call of Caplin Point Laboratories, hosted by Ashika Stock Broking. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Shrikant Akolkar from Ashika Stock Broking. Thank you, and over to you, sir.

Shrikant Akolkar;Partheeban Vivek Siddarth
Ashika Stock Broking Limited, Research Division - Senior Research Analyst;Caplin Point Laboratories Limited - COO

Thanks, Margaret. Good afternoon, everyone. This is Shrikant from Ashika institutional equities team. I thank the Caplin Point Laboratories management for giving us an opportunity to host this call today. From the management side, we have Mr. C. C. Paarthipan, Chairman; Mr. Vivek Partheeban, Chief Operating Officer; Dr. Sridhar Ganesan, Managing Director; Mr. D. Muralidharan, CFO; and Mr. M. Sathya Narayanan, Deputy CFO. Along with them, Mr. Vinod Kumar has joined as the Company Secretary.

Thank you, and over to you, Vivek.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot